| enoxaparin sodium / Generic mfg. |
2021-000099-12: Dose-adjustment of enoxaparin by a bayesian pharmacological approach in pediatric renal transplant recipients Ajustement de dose de l’énoxaparine par une approche pharmacologique bayésienne chez les receveurs transplantés rénaux pédiatriques |
|
|
| Not yet recruiting | 3 | 50 | Europe | Enoxaparin, Solution for injection in pre-filled syringe | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, DGOS | Allograft vascular thrombosis Thrombose vasculaire allogreffe, Allograft vascular thrombosis Thrombose vasculaire allogreffe, Not possible to specify | | | | |
ACTRN12621000478819: A study to find the effect of different enoxaparin doses used on stroke occurrence after brain aneurysm coiling or stenting |
|
|
| Recruiting | 3 | 124 | | | Royal Brisbane and Women's Hospital, Royal Australian and New Zealand College of Radiologists, Royal Brisbane and Women's Hospital | Intracranial aneurysm, Stroke | | | | |
2011-002992-40: Prevention of venous thromboembolism in patients with intracranial hemorrhage Prevezione del tromboembolismo venoso nei pazienti con emorragia cerebrale |
|
|
| Ongoing | 3 | 406 | Europe | Solution for injection, CLEXANE*6SIR 4000UI 0,4ML | UNIVERSITA' DEGLI STUDI DI PERUGIA, Dipartimento Medicina Interna | Spontaneous intracranial hemorrhage Pazienti con emorragia cerebrale intraparenchimale spontanea, Intracranial hemorrhage emorragia cerebrale, Diseases [C] - Nervous System Diseases [C10] | | | | |
2015-002357-35: Anticoagulants (blooding thinning medications) for pregnant women who have suffered 2 or more miscarriages and inherited thrombophilia (increased clotting tendency) |
|
|
| Ongoing | 3 | 400 | Europe | Enoxaparin Sodium, Dalteparin Sodium, Tinzaparin Sodium, Solution for injection in pre-filled syringe, Clexane, Fragmin, Innohep | Research, Development & Innovation Department, UHCW NHS Trust, Research for Patient Benefit | Inherited thrombophilia in recurrent miscarriage, Increased clotting tendency in women who have experienced 2 or more miscarriages, Diseases [C] - Blood and lymphatic diseases [C15] | | | | |
2005-006113-40: Untersuchung der Modulation der Endothelfunktion durch Enoxaparin bei Patienten mit Koronarkrankheit. Bedeutung der Enoxaparin-vermittelten Dissoziation endothelial gebundener Oxidasen für die Regulation der endothelialen Bioverfügbarkeit von NO bei Patienten mit Koronarkrankheit. |
|
|
| Ongoing | 3 | 64 | Europe | Enoxaparin, 2614-X894, | Universitäres Herzzentrum Hamburg | Stabile koronare Herzerkrankung | | | | |
2006-004205-26: A Randomised controlled tiral to evaluate the efficacy of low molecular-weight heparin on pregnancy outcome of women with previus pregnancy complication |
|
|
| Ongoing | 3 | 266 | Europe | CLEXANE*6SIR 4000UI/0,4ML, SELEPARINA*6SIR 0,4ML 3800UI, CLEXANE*6SIR 4000UI/0,4ML, SELEPARINA*6SIR 0,4ML 3800UI | OSPEDALE MAGGIORE DI MILANO IRCCS | To asses wether the treatment with LMWH in Women with previus pregnancy complications and no evidence of anatomical, endocrine, Cromosmal or immunological abnormality result in a 40 reduction in the rate of expected complication estimatedv as 40 . | | | | |
2010-023597-39: HEPARINA DE BAJO PESO MOLECULAR (HBPM) para la prevención de complicaciones derivadas de la insuficiencia placentaria en las pacientes de riesgo sin trombofilia: ensayo clÃnico multicéntrico randomizado |
|
|
| Ongoing | 3 | 361 | Europe | CLEXANE 40 mg (4000 U.I.) solución inyectable en jeringa precargada, CLEXANE 40 mg (4000 U.I.) solución inyectable en jeringa precargada | LluÃs Cabero Roura | Complicaciones de la gestación derivadas de la insuficiencia placentaria: preeclampsia, restricción decrecimiento intrauterino, desprendimiento de placenta normalmente inserta y óbito fetal. | | | | |
2012-001447-43: Anticoagulants for living fetuses for women with recurrent miscarriage and inherited blood clotting disorders; ALIFE2 study |
|
|
| Ongoing | 3 | 399 | Europe | LOVENOX, Suspension for injection in pre-filled pen, Clexane/Lovenox | Academic Medical Center Amsterdam, Academic Medical Center Amsterdam | recurrent miscarriage and inherited thrombophilia, recurrent miscarriage and inherited blood clotting disorder, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13] | | | | |
2020-002214-40: ENOXAPARIN AT PROPHYLACTIC OR THERAPEUTIC DOSES WITH MONITORING OF OUTCOMES IN SUBJECTS INFECTED WITH COVID-19 ENOXAPARINA A DOSI PROFILATTICHE O TERAPEUTICHE CON MONITORAGGIO DEI RISULTATI NEI SOGGETTI INFETTI DA COVID-19 |
|
|
| Not yet recruiting | 3 | 300 | Europe | Enoxaparina, enoxaparina, [Enoxaparina], [enoxaparina], Solution for injection in pre-filled syringe | ASST FATEBENEFRATELLI SACCO | SARS-CoV-2 related pneumonia Polmonite da SARS-CoV-2, Coranavirus related pneumonia Polmonite da coronavirus, Diseases [C] - Virus Diseases [C02] | | | | |
NCT04462003: Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis |
|
|
| Recruiting | 3 | 100 | RoW | Apixaban, Enoxaparin | Beni-Suef University | Deep Vein Thrombosis, Malignancy | 07/20 | 07/20 | | |
ETERNITY, NCT03083184: Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients |
|
|
| Recruiting | 3 | 400 | Europe | Ethanol, enoxaparin | University Hospital, Clermont-Ferrand, Ministry of Health, France, CH du Puy en Velay, Hôpital Emile Roux, University Hospital, Toulouse, Centre hospitalier de Chambéry, Calydial, Hôpital Edouard Herriot, Nouvel Hôpital Civil, 1 place de l'Hôpital 67091 Strasbourg cedex, Hôpital Lapeyronie, Centre de dialyse d'Alès, University Hospital of Saint-Etienne, Centre hospitalier de Perpignan, Centre de néphrologie Polyclinique Médipôle Saint-Roch, Rue Ambroise Croizat, CHU Hôpital Maison Blanche, 45 Rue Cognacq-Jay 51092 REIMS Cedex | Tunnelled Hemodialysis Catheter Infection | 12/26 | 12/27 | | |
2020-002190-10: A Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic |
|
|
| Ongoing | 3 | 462 | Europe | Clexane (Enoxaparin sodium), Solution for injection in pre-filled syringe, Clexane (enoxaparin sodium) | University College Dublin, University College Dublin | Coagulopathy of COVID-19 appears to afflict approximately 20% of patients with severe COVID-19 and is associated with need for critical care and death. COVID-19 coagulopathy is characterized by elevated D-dimer, an indicator of fibrin formation and clot lysis, and a mildly prolonged prothrombin time (PT), suggestive of coagulation consumption, Excessive blood clotting as a result of a severe inflammatory response appears to afflict approximately 20% of patients with severe COVID-19 and is associated with need for critical care and death., Diseases [C] - Virus Diseases [C02] | | | | |
2020-005963-29: Clinical trial of anti-coagulant drug for COVID-19 inpatients Klinisk forsøg med blodfortyndende lægemiddel til COVID-19 indlagte patienter |
|
|
| Not yet recruiting | 3 | 2400 | Europe | Tinzeparin, Enoxaparin, Dalteparin, Injection, Innohep, Klexane, Fragmin | University of Melbourne, University of Melbourne | COVID-19 COVID-19, COVID-19 after infection with SARS-CoV-2 COVID-19 efter infektion med Ny Coronavirus, Diseases [C] - Virus Diseases [C02] | | | | |
2020-005884-29: ROLE OF HEPARIN IN THE PREVENTION OF THROMBOEMBOLISM IN PATIENTS WITH COVID-19 AND RESPIRATORY FAILURE RUOLO DELL'EPARINA NELLA PREVENZIONE DEL TROMBOEMBOLISMO IN PAZIENTI CON COVID-19 E INSUFFICIENZA RESPIRATORIA |
|
|
| Not yet recruiting | 3 | 652 | Europe | Parnaparina, Dalteparina, Nadroparina, Bemiparina, Reviparina, Enoxaparina, [Antitrombotici - derivati dell’eparina], Solution for injection | UNIVERSITà DEGLI STUDI DI PERUGIA | Patients with confirmed SARS-CoV-2 infection and respiratory failure will be randomized to receive two different doses of low molecular weight heparin (LMWH). Pazienti con infezione confermata da SARS-CoV-2 e insufficienza respiratoria saranno randomizzati a ricevere due diversi tipi di dosaggi di eparina a basso peso molecolare (EBPM)., Patients with confirmed SARS-CoV-2 infection and respiratory failure. Pazienti con infezione confermata da SARS-CoV-2 e insufficienza respiratoria., Diseases [C] - Virus Diseases [C02] | | | | |
2020-005624-10: The OVID study will show whether prophylactic-dose enoxaparin improves survival and reduces any hospitalizations in ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and coagulation activation |
|
|
| Ongoing | 3 | 1000 | Europe | Clexane (enoxaparin sodium), Solution for injection in pre-filled syringe, Clexane (enoxaparin sodium) | University Hospital Zurich, Clinic of Angiology, Universitaetsspital Zuerich, Schweizerischer Nationalfunds (SNF) | Patients diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and coagulation activation., COVID-19 Infection, Diseases [C] - Virus Diseases [C02] | | | | |
2020-005890-29: Multi-arm randomized trial, comparing the efficacy of therapeutic strategies for at home early treatment of mild or moderate COVID-19 (SARS-CoV-2 infection) patients on the reduction of the risk of disease worsening Studio a più bracci di trattamento, casualmente assegnati, che confronta l'efficacia degli schemi terapeutici per il trattamento domiciliare precoce di pazienti con COVID-19 (infezione da SARS-CoV-2) lieve o moderata nel ridurre il rischio di peggioramento della malattia |
|
|
| Not yet recruiting | 3 | 810 | Europe | Paracetamolo, Celecoxib, Enoxaparina, [Paracetamolo], [Celecoxib], [Enoxaparina], Tablet, Capsule, hard, Solution for injection in pre-filled syringe | FONDAZIONE RICERCA TRASLAZIONALE (FORT) | Mild or moderate COVID-19 (Coronavirus Disease 19), not requiring hospitalization COVID-19 (Malattia da Coronavirus 19) lieve o moderata, che non richiede ospedalizzazione, Mild or moderate COVID-19 (Coronavirus Disease 19), not requiring hospitalization COVID-19 (Malattia da Coronavirus 19) lieve o moderata, che non richiede ospedalizzazione, Diseases [C] - Virus Diseases [C02] | | | | |
| Completed | 3 | 142 | Europe | Enoxaparin, Clexane | ASST Fatebenefratelli Sacco, Massimo Arquati, Riccardo Colombo, Umberto Russo, Manuela Nebuloni, Spinello Antinori | Covid19, Thrombosis | 10/22 | 04/23 | | |
FiXET, NCT02486666: Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose |
|
|
| Recruiting | 3 | 20 | Canada, US | Enoxaparin, Enoxaparin sodium | Hamilton Health Sciences Corporation, IWK Health Centre, Children's Hospital of Philadelphia, Children's Hospital of Eastern Ontario | Venous Thromboembolism | 12/22 | 12/22 | | |
NCT02715492: Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma. |
|
|
| Not yet recruiting | 3 | 40 | RoW | LMWH, Enoxaparin, TACE | Sherief Abd-Elsalam | HCC | 12/22 | 12/22 | | |
| Recruiting | 3 | 330 | Europe | Heparin, Unfractionated heparin, LMWH, Dalteparine, Enoxaparine, Nadroparine, Tinzaparine | University Medical Center Groningen, ZonMw: The Netherlands Organisation for Health Research and Development, Erasmus Medical Center, Leiden University Medical Center, St. Antonius Hospital, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Isala, OLVG, Radboud University | Heart Failure, Respiratory Failure, Extracorporeal Membrane Oxygenation, Bleeding, Thrombosis | 03/23 | 03/24 | | |
PP-HEP, NCT05878899: Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial |
|
|
| Completed | 3 | 77 | Europe | Enoxaparin | University Hospital, Geneva | Venous Thromboembolism | 03/23 | 03/23 | | |
| Not yet recruiting | 3 | 10044 | NA | Rivaroxaban, Apixaban, Enoxaparin Injectable Solution, Tinzaparin Injectable Solution, Dalteparin Injectable Solution, Fondaparinux Injectable Product | Queen Mary University of London | Thrombosis, Injury Leg | 02/28 | 02/28 | | |
| Not yet recruiting | 3 | 50 | Canada | Redesca (enoxaparin sodium for injection), Fragmin (dalteparin) | Western University, Canada, Valeo Pharma Inc | Hepatic Disease, Surgery-Complications, Hypercoagulability, Thrombosis | 02/25 | 02/28 | | |
VALERIA, NCT04999176: Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin |
|
|
| Recruiting | 3 | 440 | RoW | Rivaroxaban, Xarelto, Enoxaparin, Clexane | André Luiz Malavasi Longo de Oliveira, Science Valley Research Institute | Cancer, Rivaroxaban, Venous Thromboembolism, Thromboprophylaxis | 07/24 | 07/24 | | |
| Enrolling by invitation | 3 | 120 | Europe | subcutaneous Enoxaparin, experimental, standard of care | Centro Hospitalar de Lisboa Central, NOVA Medical School | Fetal Growth Retardation, Prematurity, Pre-Eclampsia | 12/24 | 07/25 | | |
| Active, not recruiting | 3 | 2200 | RoW | (Arm Closed) Nafamostat Mesilate, Nafabelltan, (Arm Closed) Enoxaparin, (Arm Closed) Dalteparin, (Arm Closed) Tinzaparin, (Arm Never Opened) Hyperimmune globulin, Nirmatrelvir-Ritonavir, Paxlovid, Remdesivir, Veklury | University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Australasian Society for Infectious Diseases, Hunter Medical Research Institute, Aotearoa Clinical Trials, Australian and New Zealand Intensive Care Research Centre | SARS-CoV-2 Infection (COVID-19) | 07/25 | 12/25 | | |
| Recruiting | 2/3 | 40 | Canada | Subcutaneous Heparin, Enoxaparin or unfractionated heparin | Damian Ratano, PSI Foundation, Toronto, Ontario | Extracorporeal Membrane Oxygenation Complication | 12/23 | 06/24 | | |
| Recruiting | 2/3 | 258 | US | Enoxaparin, Lovenox, Clexane | Yale University, Children's Hospital Colorado, Children's Hospital of Philadelphia, Virginia Commonwealth University, BJC HealthCare, Medical College of Wisconsin, Children's of Alabama, Golisano Children's Hospital, Maria Fareri Children's Hospital, Nationwide Children's Hospital, New York Presbyterian Hospital, Penn State University, University of Iowa, Johns Hopkins All Children's Hospital, University of Oklahoma, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Deep Venous Thrombosis | 04/26 | 07/26 | | |
